Ursodeoxycholic acid to prevent gallstone pancreatitis returning
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether ursodeoxycholic acid (a bile medicine) can help prevent complications from gallstone-related acute pancreatitis from coming back after you leave the hospital. It may help reduce repeat problems linked to gallstones, especially after an initial pancreatitis episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted to the hospital for acute pancreatitis (doctors diagnosed it using symptoms, blood tests, and/or scans)
- Gallstones must be seen on imaging
- Have not had gallbladder removal or certain drainage/endoscopy procedures before joining the study
- Be willing and able to return for follow-up, and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a procedure using an endoscope (a thin, flexible tube) can help prevent future gallbladder problems in people who have had pancreatitis from gallstones but cannot have surgery.
This trial tests if removing the gallbladder can prevent future episodes of unexplained acute pancreatitis. It may help people who've had one to three episodes with no clear cause found.
This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.
This trial tests whether performing an ERCP (a procedure to clear bile duct stones) soon after a mild gallstone-related pancreatitis attack can prevent future problems in patients who choose not to have their gallbladder removed.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
This phase 3 trial tests duloxetine for preventing pancreatitis after ERCP in adults with normal baseline amylase/lipase and without certain comorbidities.
Hear when a new Acute Pancreatitis Due to Gallstones trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.